Propel Bio Management, LLC AKRO Holdings History
Propel Bio Management, LLC's Akero Therapeutics Inc Holding Summary
As of 2025-03-31, Propel Bio Management, LLC held 228,884.00 shares of Akero Therapeutics Inc(AKRO), totaling $9.27 Mil. This investment constitutes 10.9% of their stock portfolio, and Propel Bio Management, LLC now holds 0.29% of the outstanding Akero Therapeutics Inc(AKRO) stock.
The initial trade took place in 2023Q4. And since then Propel Bio Management, LLC has made 2 purchases of AKRO, at an average price of $22.86, for a total of 343,729.00 shares. In addition, there have been 1 sales at an average price of $42.39 for 114,845.00 shares. Based on historical transaction data and AKRO's current price of $51.11, Propel Bio Management, LLC's estimated gain on his AKRO holdings is $8.71 Mil, reflecting a 110.79% gain to date.
Propel Bio Management, LLC AKRO ($51.11) Holding Chart
Propel Bio Management, LLC AKRO ($51.11) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
